Spine Pain Management to Generate nearly US$ 12.5 Billion in Revenue by 2033 | FMI
According to Future Market Insights’ recent report, the Spine Pain Market is forecast to register a CAGR of 5% from 2023-2033, reaching a valuation of US$ 12.47 Billion. Anti-inflammatory medications' minor side effects are encouraging an increase in their usage as pain relievers. The effectiveness of pharmaceuticals like diclofenac, ibuprofen, and naproxen as nonsteroidal anti-inflammatory treatments is aiding the sector's growth. The vast majority of individuals in the region who suffer from chronic spine pain contribute to the market's expansion. Because of rising healthcare costs for the general public and the availability of cutting-edge healthcare systems, the industry for spine pain treatment in North America is gaining momentum. People are becoming more conscious of spine pain, which is expected to increase demand for this treatment in the region. Get Full Access @ https://www.futuremarketinsights.com/reports/spine-pain-market The APAC market, on the other...